Mpox Emergency Ends in 2023

According to reporting by The Hill, the public health emergency (PHE) for the mpox outbreak that began in May 2022 has been discontinued as of January 31, 2023. 

The U.S. administration announced in December 2022 that it was not expecting to renew the PHE for Mpox, which was initially declared in August 2022 and renewed in November.

During the outbreak in the U.S., the Centers for Disease Control and Prevention (CDC) reported 30,093 cases and 26 related fatalities.

And in Europe, the five countries reporting the most Mpox cases since the start of the outbreak are Spain (7,528), France (4,127), Germany (3,676), Netherlands (1,260), and Italy (954).

Furthermore, the CDC confirmed about one million first and second doses of Bavarian Nordic's JYNNEOS® (MVA-BN) vaccine had been administered during the emergency.

The CDC says that two doses of the U.S. FDA-approved vaccine provide the best protection (~70%), regardless of how the vaccine was administered.

One dose offers less than 40% protection from this sexually transmitted disease.

Other outbreak news is posted at MonkeypoxToday.com.